James and Jessica dive into this week's healthtech headlines, a CRISPR therapy that halves cholesterol in a first-in-human trial, the Health Foundation's £33bn case for better NHS tech, Oura scrapping its Nasdaq IPO, and why Jessica has broken up with her smart ring.
🗞 Grab the newsletter at www.healthtechpigeon.com
✍️ Apply to be a podcast guest using this form: https://share.hsforms.com/1PkAwCjniQjiGl53i8dtZ8g3xer2
📖 Learn more about the SomX team at https://somx.health
